GlassScriptPhysician profile
Jessica Peffer
NPI 1467187757
$1,149.09
in general payments reported to CMS, 2019-2025
16 companies · $346 in 2025
The $346 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $203 · 2023: $299 · 2024: $301 · 2025: $346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $946.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $946.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $268.52 | 2022-2025 | Mounjaro, Zepbound, Emgality |
| Novo Nordisk INC | $234.90 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $165.00 | 2022-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $91.43 | 2023 | Lifevest |
| Boston Scientific Corporation | $77.31 | 2024 | Watchman Flx |
| Astrazeneca Pharmaceuticals LP | $72.42 | 2023-2024 | Farxiga, Airsupra |
| Biohaven Pharmaceutical Holding Company LTD. | $53.17 | 2022 | |
| Dexcom, INC. | $42.07 | 2024-2025 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $32.88 | 2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $21.71 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $16.36 | 2023 | Opsumit |
| Janssen Pharmaceuticals, INC | $16.31 | 2023 | Xarelto |
| Kowa Pharmaceuticals America, INC. | $14.72 | 2022 | |
| Amgen INC. | $14.42 | 2023 | Otezla, Repatha |
| Sanofi-Aventis U.S. LLC | $14.11 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $13.76 | 2025 | Flexitouch Plus, Nimbl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Peffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.